A Phase 1 Study to Evaluate the Effects of Rifampin on Pharmacokinetics of Pevonedistat in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2018
At a glance
- Drugs Pevonedistat (Primary) ; Carboplatin; Docetaxel; Paclitaxel; Rifampicin
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Takeda Oncology
- 05 Sep 2018 Status changed from not yet recruiting to recruiting.
- 02 Aug 2018 Planned initiation date changed from 16 Jul 2018 to 17 Sep 2018.
- 16 Apr 2018 Planned initiation date changed from 3 Apr 2018 to 16 Jul 2018.